The impact of post-remission granulocyte colony-stimulating factor use in the phase 3 studies of venetoclax combination treatments in patients with newly diagnosed acute myeloid leukemia
| dc.contributor.author | DiNardo, Courtney D. | |
| dc.contributor.author | Pratz, Keith W. | |
| dc.contributor.author | Panayiotidis, Panayiotis | |
| dc.contributor.author | Wei, Xudong | |
| dc.contributor.author | Vorobyev, Vladimir | |
| dc.contributor.author | Illés, Árpád | |
| dc.contributor.author | Kim, Inho | |
| dc.contributor.author | Ivanov, Vladimir | |
| dc.contributor.author | Ku, Grace | |
| dc.contributor.author | Miller, Catherine | |
| dc.contributor.author | Zhang, Meng | |
| dc.contributor.author | Tatsch, Fernando | |
| dc.contributor.author | Potluri, Jalaja | |
| dc.contributor.author | Schmidt, Xenia | |
| dc.contributor.author | Récher, Christian | |
| dc.date.accessioned | 2025-02-21T08:32:38Z | |
| dc.date.available | 2025-02-21T08:32:38Z | |
| dc.date.issued | 2024 | |
| dc.date.oa | 2025-06-19 | |
| dc.date.pasync | 2025-05-05T23:09:02Z | |
| dc.date.updated | 2025-02-21T08:32:38Z | |
| dc.description.corrector | kzs | |
| dc.identifier.citation | American Journal Of Hematology. -100 : 1 (2024), p. 185-188. -Am. J. Hematol. - 0361-8609 1096-8652 | |
| dc.identifier.doi | http://dx.doi.org/10.1002/ajh.27515 | |
| dc.identifier.issn | 1096-8652 | |
| dc.identifier.issn | 0361-8609 | |
| dc.identifier.opac | https://ebib.lib.unideb.hu/ebib/CorvinaWeb?action=cclfind&resultview=long&ccltext=idno+BIBFORM128007 | |
| dc.identifier.scopus | 85208026406 | |
| dc.identifier.uri | https://hdl.handle.net/2437/387266 | |
| dc.identifier.url | https://onlinelibrary.wiley.com/doi/10.1002/ajh.27515 | |
| dc.identifier.wos | 001358263600001 | |
| dc.language | eng | |
| dc.rights.access | open access article | |
| dc.rights.owner | szerző | |
| dc.subject.mab | Orvostudományok | |
| dc.subject.mab | Klinikai orvostudományok | |
| dc.title | The impact of post-remission granulocyte colony-stimulating factor use in the phase 3 studies of venetoclax combination treatments in patients with newly diagnosed acute myeloid leukemia | |
| dc.type | folyóiratcikk | |
| dc.type | levél |
Fájlok
Eredeti köteg (ORIGINAL bundle)
1 - 1 (Összesen 1)
Nincs kép
- Név:
- FILE_UP_0_American J Hematol - 2024 - DiNardo - The impact of post‐remission granulocyte colony‐stimulating factor use in the phase 3.pdf
- Méret:
- 952.62 KB
- Formátum:
- Adobe Portable Document Format
- Leírás:
- kiadói változat